Dolby Cinema at AMC Opens Its 100th Location SAN FRANCISCO

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
22
Dolby Cinema at AMC Opens Its 100th Location

SAN FRANCISCO and LEAWOOD, Kan., May 24, 2018 (GLOBE NEWSWIRE) -- Dolby Cinema at AMC , the total cinema experience, is now available to more movie-going fans than ever, as AMC Theatres (NYSE: AMC ) and Dolby Laboratories, Inc. (NYSE: DLB ) celebrate the 100th Dolby Cinema at AMC location opening at AMC Loews 34th Street 14 in New York City. As a testament to the rapid growth of Dolby Cinema across the United States, the 100th site is being opened just three years after the first. The original agreement, reached in 2015, was for 100 auditoriums over a 10-year deployment.

Dolby Cinema begins with the filmmakers' vision—using the full storytelling capabilities that Dolby offers in image and sound production to transform the way movies are made and presented. With state-of-the-art image, sound, and seating, movies come to life to deliver cinema in its purest form.

“Opening the 100th Dolby Cinema at AMC location is a momentous event,” said Doug Darrow, Senior Vice President, Cinema Business Group, Dolby Laboratories. “Dolby and AMC embrace a shared passion to deliver a best-in-class, unforgettable entertainment experience. Our growth was made possible by the incredible response from moviegoers, studios, and filmmakers.”

“Dolby Cinema at AMC provides an unparalleled movie-going experience and the guest response around the country has been remarkable,” said John McDonald, Executive Vice President, US Operations, AMC. “To reach 100 locations in just three years is a testament to the strong partnership between Dolby and AMC, but also to the strong preference of moviegoers to enjoy their movies in the powerful and captivating environment that Dolby Cinema at AMC provides.”

Dolby Cinema at AMC  delivers the total cinema experience via dramatic imaging with Dolby Vision laser projection, moving audio with Dolby Atmos immersive sound, and innovative seating with reservable recliners.

Guests of Dolby Cinema at AMC can expect:

DRAMATIC IMAGING — The Dolby Vision laser projection system, which uses state-of-the-art optics and image processing, delivers high dynamic range with enhanced color technology and a contrast ratio that far exceeds that of any other image technology on the market today. As a result, the picture comes alive with astonishing brightness and captivating color that more closely matches what the eye can see.

MOVING AUDIO — Guests are transported inside the story with Dolby Atmos immersive sound that flows all around them, even overhead, placing the audience deeper inside the film's setting with breathtaking realism that creates a powerfully moving experience.

INNOVATIVE SEATING — Moviegoers enjoy next-level comfort with spacious, reserved recliners that pulsate with the action in the exclusive AMC Signature Recliners.

Hollywood’s commitment to Dolby Cinema remains strong, with over 165 feature releases mastered specifically for the format. Many of 2018's most anticipated releases will be shown at Dolby Cinema at AMC locations across the United States, including  Solo: A Star Wars Story, Ocean’s 8, Incredibles 2, Jurassic World: Fallen Kingdom ,  Mission: Impossible – Fallou t , Mamma Mia! Here We Go Again, The Equalizer 2, BlacKkKlansman, Venom , A Star is Born, Bohemian Rhapsody , Fantastic Beasts: The Crimes of Grindelwald , Aquaman , plus more! 

For Dolby Cinema at AMC tickets and showtimes, visit  www.amctheatres.com/dolby . You can also visit  www.dolby.com/movies  to learn more about what's playing at Dolby Cinema.

About Dolby Laboratories Dolby Laboratories  (NYSE: DLB ) is based in San Francisco with offices in over 20 countries around the globe. Dolby transforms the science of sight and sound into spectacular experiences. Through innovative research and engineering, we create breakthrough experiences for billions of people worldwide through a collaborative ecosystem spanning artists, businesses, and consumers. The experiences people have – in Dolby  Vision , Dolby  Atmos , Dolby  Cinema , Dolby  Voice , and Dolby  Audio  – revolutionize entertainment and communications at the cinema, on the go, in the home, and at work.

About AMC AMC is the largest movie exhibition company in the U.S., in Europe and throughout the world with approximately 1,000 theatres and 11,000 screens across the globe. AMC has propelled innovation in the exhibition industry by: deploying more plush power-recliner seats; delivering enhanced food and beverage choices; generating greater guest engagement through its loyalty program, web site and smart phone apps; offering premium large format experiences and playing a wide variety of content including the latest Hollywood releases and independent programming. AMC operates among the most productive theatres in the United States' top markets, having the #1 or #2 market share positions in 22 of the 25 largest metropolitan areas of the United States, including the top three markets (NY, LA, Chicago). Through its Odeon subsidiary AMC operates in 14 European countries and is the # 1 theatre chain in UK & Ireland, Italy, Spain, Sweden, Finland and the Baltic States. www.amctheatres.com.

Dolby, Dolby Atmos, and the double-D symbol are registered trademarks of Dolby Laboratories. Dolby Cinema and Dolby Vision are trademarks of Dolby Laboratories. All other trademarks remain the property of their respective owners. DLB-G

Media Contact

Dolby Laboratories Natalia Sandin +1-650-201-8814  Natalia.Sandin@dolby.com   or  Darren Murph +1-415-357-7043 Darren.Murph@dolby.com or AMC Theatres Ryan Noonan +1-913-213-2183 RNoonan@amctheatres.com

Scroll down for more posts ▼

Top 10 Most Recent News Articles

NARUTO Card Game Set for June 2027 Global Launch

Updated Category News Views 8

Mark Your Calendars: Global Launch June 2027 They're rolling out a red carpet for nostalgia here, I tell ya! At the New York Comic Con, BANDAI announced a worldwide launch for the NARUTO CARD GAME in June 2027. We'll see pre-built decks starring your favorite shinobi and a mad sprint to collect with the new booster packs. Feels sort of like they’re summoning a jutsu...

Continue Reading
AbbVie's SKYRIZI and RINVOQ Highlight IBD Control Advances

Updated Category News Views 3

A Deeper Look Into AbbVie's Latest Data Let's cut straight to the science, folks. At the recent American College of Gastroenterology 2026 Annual Scientific Meeting, AbbVie pulled the curtain on 22 fresh scientific abstracts that are really shaking things up in the field of inflammatory bowel disease (IBD) treatment. Data from the Phase 3 AFFIRM study shined especially...

Continue Reading
2026 Community Impact Week: Slam Dunk for Community Unity

Updated Category News Views 5

Alright, if you're looking for a story that gives you those warm fuzzy feelings while wrapping you in a big sports hug, here it is. Imagine this: you've got basketball legends, world-class athletes, and a corporate heavyweight, all huddling up to make a community impact that's more than just warm air. Hoops, Hope, and High Fives The NBA Cares x Sands Cares Community...

Continue Reading
Sebela Pharma's Tegoprazan Posts Strong Phase 3 Data

Updated Category News Views 6

Spotlight on Tegoprazan: A New Player on the GERD Field Sometimes, a pharma company turns heads with data that speaks for itself. This time, Sebela Pharmaceuticals is doing just that with Tegoprazan's phase 3 results, shining a light on an area overlooked for too long: non-erosive reflux disease (NERD). Showing promise in its latest trials, Tegoprazan is muscling into the...

Continue Reading
Duolingo Faces Lawsuit Over Alleged Investor Missteps

Updated Category News Views 9

Fasten your seatbelts, folks. We're diving into a legal tussle that could shake things up for Duolingo, Inc. (NASDAQ: DUOL). Investors who plunged into Duolingo shares between May 2, 2025, and February 26, 2026, might be feeling the heat now. They ought to brace for a class-action lawsuit frenzy with fingers pointed at Duolingo for allegedly pulling wool over investors'...

Continue Reading
AI Drives Major Time Savings in Endoscopy Tech

Updated Category News Views 9

AI in Endoscopy: Game-Changer or Gimmick? Stumbling across AnX Robotica's latest pitch about their NaviCam ProScan AI workflow, one can't help but feel a mix of curiosity and skepticism. With the stakes in medical tech sky-high, they've fired off some impressive stats that grab attention. We're talking about cutting small-bowel capsule review times by a whopping...

Continue Reading
Phase I of 2026 Hong Kong Trade Shows Highlights Innovation

Updated Category News Views 8

Hong Kong Takes Center Stage in Global Commerce Flip through the economic landscape today, and you’ll spot Hong Kong, decked out in its best as a trade linchpin—with over 2,100 suppliers gathered under one roof. AsiaWorld-Expo is buzzing with the commencement of Phase I of the October 2026 Global Sources Hong Kong Shows. The theme's all about 'Connecting Global...

Continue Reading
Southern Company Sparks Swift Power Restoration Post-Isaias

Updated Category News Views 10

Well, when Mother Nature decides to throw a tantrum, it takes seasoned hands and savvy tech to clean up the mess. That's exactly what Southern Company is doing after Hurricane Isaias wreaked havoc on the Southeast. With their electric utilities—Alabama Power, Georgia Power, and Mississippi Power—hitting the ground running, they've already restored power to a whopping...

Continue Reading
Pacira BioSciences Faces Shareholder Revolt in M&A Deal

Updated Category News Views 3

A New Storm Brews Over Pacira's Sale to Viatris They say where there's smoke, there's fire, and it looks like Pacira BioSciences, Inc. (NASDAQ: PCRX) is running right into a bonfire thanks to their upcoming sale to Viatris Inc. On the face of it, shareholders are looking at a tidy $36.50 in cash per share, but not everyone's buying the deal as fair. Enter lawman Juan...

Continue Reading
Celltrion Unveils New Data on Infliximab: ACG 2026 Insight

Updated Category News Views 3

First Impressions: Celltrion's Latest Revelation Alright, let's jump straight into it. Celltrion USA is flaunting its latest findings on ZYMFENTRA® (infliximab-dyyb) for Crohn's disease and ulcerative colitis right at the American College of Gastroenterology's (ACG) grand event in 2026. If you've been watching the healthcare sector, this is significant news. It's got all...

Continue Reading

Top 5 Most Recently Viewed Articles

Bryan Leon Joins Storm Properties to Elevate Acquisitions Team

Updated Category News Views 381

Storm Properties Welcomes Bryan Leon as New Hire Storm Properties Inc., recognized as a significant player in the development, ownership, and management of a variety of properties, is delighted to announce the addition of Bryan Leon to their team as Land Acquisitions Manager. This appointment comes as part of the company's ongoing strategy to strengthen its position in...

Continue Reading
Revolutionizing Trade Setups with Innovative Scanner Technology

Updated Category News Views 280

Revolutionizing Trade Setups with Innovative Scanner Technology Stock Market Guides is thrilled to introduce significant advancements to its cutting-edge stock scanner technology. The latest update empowers users by showcasing the historical track record of various trade setups it identifies, offering unparalleled insight to traders looking to enhance their market...

Continue Reading
EQT Life Sciences Champions $39 Million Investment in Aerska

Updated Category News Views 101

EQT Life Sciences Champions $39 Million Investment in Aerska Advancing RNA Therapeutics EQT Life Sciences has recently announced a significant milestone: leading a $39 million Series A financing round in Aerska. This funding will be instrumental in pushing forward Aerska’s innovative brain shuttle technology. Designed to optimize the delivery of RNA interference...

Continue Reading
NVIDIA's Anticipated Earnings Report: Key Insights for Investors

Updated Category News Views 160

Understanding NVIDIA's Upcoming Earnings Announcement NVIDIA (NASDAQ: NVDA) is set to release its much-anticipated quarterly earnings report soon. Investors are keen to understand how the company is performing and what guidance it will provide for future quarters. Analysts predict that NVIDIA will announce an earnings per share (EPS) of $0.98, which indicates the level of...

Continue Reading
Innovative Partnership Forged for Enhanced Vehicle Safety

Updated Category News Views 185

Innovative Partnership Forged for Enhanced Vehicle Safety NOVOSENSE Microelectronics, a key player in the semiconductor industry known for its high-performance analog and mixed-signal chips, is joining hands with Continental Automotive Technologies to enhance vehicle safety systems. This collaboration aims to push the envelope in developing automotive-grade sensors that...

Continue Reading